United States Crohns Disease Drug Market Report 2016

United States Crohn's Disease Drug Market Report 2016

1 Crohn's Disease Drug Overview

1.1 Product Overview and Scope of Crohn's Disease Drug

1.2 Classification of Crohn's Disease Drug

1.2.1 Aminosalicylates (5-ASA)

1.2.2 Corticosteroids

1.2.3 Immunomodulators

1.2.4 Antibiotics

1.3 Application of Crohn's Disease Drug

1.3.1 Achieving remission (the absence of symptoms)

1.3.2 Maintaining remission (prevention of flare-ups)

1.3.3 Pediatric Crohn's Disease

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Crohn's Disease Drug (2011-2021)

1.4.1 United States Crohn's Disease Drug Sales and Growth Rate (2011-2021)

1.4.2 United States Crohn's Disease Drug Revenue and Growth Rate (2011-2021)

2 United States Crohn's Disease Drug Competition by Manufacturers

2.1 United States Crohn's Disease Drug Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Crohn's Disease Drug Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Crohn's Disease Drug Average Price by Manufactures (2015 and 2016)

2.4 Crohn's Disease Drug Market Competitive Situation and Trends

2.4.1 Crohn's Disease Drug Market Concentration Rate

2.4.2 Crohn's Disease Drug Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Crohn's Disease Drug Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Crohn's Disease Drug Sales and Market Share by Type (2011-2016)

3.2 United States Crohn's Disease Drug Revenue and Market Share by Type (2011-2016)

3.3 United States Crohn's Disease Drug Price by Type (2011-2016)

3.4 United States Crohn's Disease Drug Sales Growth Rate by Type (2011-2016)

4 United States Crohn's Disease Drug Sales (Volume) by Application (2011-2016)

4.1 United States Crohn's Disease Drug Sales and Market Share by Application (2011-2016)

4.2 United States Crohn's Disease Drug Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Crohn's Disease Drug Manufacturers Profiles/Analysis

5.1 AbbVie

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Crohn's Disease Drug Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 AbbVie Crohn's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Janssen Biotech

5.2.2 Crohn's Disease Drug Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Janssen Biotech Crohn's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Takeda Pharmaceuticals

5.3.2 Crohn's Disease Drug Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Takeda Pharmaceuticals Crohn's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 UCB

5.4.2 Crohn's Disease Drug Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 UCB Crohn's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Amgen

5.5.2 Crohn's Disease Drug Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Amgen Crohn's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Tillotts Pharma

5.6.2 Crohn's Disease Drug Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Tillotts Pharma Crohn's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

...

6 Crohn's Disease Drug Manufacturing Cost Analysis

6.1 Crohn's Disease Drug Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Crohn's Disease Drug

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Crohn's Disease Drug Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Crohn's Disease Drug Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Crohn's Disease Drug Market Forecast (2016-2021)

10.1 United States Crohn's Disease Drug Sales, Revenue Forecast (2016-2021)

10.2 United States Crohn's Disease Drug Sales Forecast by Type (2016-2021)

10.3 United States Crohn's Disease Drug Sales Forecast by Application (2016-2021)

10.4 Crohn's Disease Drug Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Crohn's Disease Drug

Table Classification of Crohn's Disease Drug

Figure United States Sales Market Share of Crohn's Disease Drug by Type in 2015

Figure Aminosalicylates (5-ASA) Picture

Figure Corticosteroids Picture

Figure Immunomodulators Picture

Figure Antibiotics Picture

Table Application of Crohn's Disease Drug

Figure United States Sales Market Share of Crohn's Disease Drug by Application in 2015

Figure Achieving remission (the absence of symptoms) Examples

Figure Maintaining remission (prevention of flare-ups) Examples

Figure Pediatric Crohn's Disease Examples

Figure United States Crohn's Disease Drug Sales and Growth Rate (2011-2021)

Figure United States Crohn's Disease Drug Revenue and Growth Rate (2011-2021)

Table United States Crohn's Disease Drug Sales of Key Manufacturers (2015 and 2016)

Table United States Crohn's Disease Drug Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Crohn's Disease Drug Sales Share by Manufacturers

Figure 2016 Crohn's Disease Drug Sales Share by Manufacturers

Table United States Crohn's Disease Drug Revenue by Manufacturers (2015 and 2016)

Table United States Crohn's Disease Drug Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Crohn's Disease Drug Revenue Share by Manufacturers

Table 2016 United States Crohn's Disease Drug Revenue Share by Manufacturers

Table United States Market Crohn's Disease Drug Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Crohn's Disease Drug Average Price of Key Manufacturers in 2015

Figure Crohn's Disease Drug Market Share of Top 3 Manufacturers

Figure Crohn's Disease Drug Market Share of Top 5 Manufacturers

Table United States Crohn's Disease Drug Sales by Type (2011-2016)

Table United States Crohn's Disease Drug Sales Share by Type (2011-2016)

Figure United States Crohn's Disease Drug Sales Market Share by Type in 2015

Table United States Crohn's Disease Drug Revenue and Market Share by Type (2011-2016)

Table United States Crohn's Disease Drug Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Crohn's Disease Drug by Type (2011-2016)

Table United States Crohn's Disease Drug Price by Type (2011-2016)

Figure United States Crohn's Disease Drug Sales Growth Rate by Type (2011-2016)

Table United States Crohn's Disease Drug Sales by Application (2011-2016)

Table United States Crohn's Disease Drug Sales Market Share by Application (2011-2016)

Figure United States Crohn's Disease Drug Sales Market Share by Application in 2015

Table United States Crohn's Disease Drug Sales Growth Rate by Application (2011-2016)

Figure United States Crohn's Disease Drug Sales Growth Rate by Application (2011-2016)

Table AbbVie Basic Information List

Table AbbVie Crohn's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Figure AbbVie Crohn's Disease Drug Sales Market Share (2011-2016)

Table Janssen Biotech Basic Information List

Table Janssen Biotech Crohn's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Janssen Biotech Crohn's Disease Drug Sales Market Share (2011-2016)

Table Takeda Pharmaceuticals Basic Information List

Table Takeda Pharmaceuticals Crohn's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Takeda Pharmaceuticals Crohn's Disease Drug Sales Market Share (2011-2016)

Table UCB Basic Information List

Table UCB Crohn's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table UCB Crohn's Disease Drug Sales Market Share (2011-2016)

Table Amgen Basic Information List

Table Amgen Crohn's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Amgen Crohn's Disease Drug Sales Market Share (2011-2016)

Table Tillotts Pharma Basic Information List

Table Tillotts Pharma Crohn's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Tillotts Pharma Crohn's Disease Drug Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Crohn's Disease Drug

Figure Manufacturing Process Analysis of Crohn's Disease Drug

Figure Crohn's Disease Drug Industrial Chain Analysis

Table Raw Materials Sources of Crohn's Disease Drug Major Manufacturers in 2015

Table Major Buyers of Crohn's Disease Drug

Table Distributors/Traders List

Figure United States Crohn's Disease Drug Production and Growth Rate Forecast (2016-2021)

Figure United States Crohn's Disease Drug Revenue and Growth Rate Forecast (2016-2021)

Table United States Crohn's Disease Drug Production Forecast by Type (2016-2021)

Table United States Crohn's Disease Drug Consumption Forecast by Application (2016-2021)